Caroline Dimech currently serves as Team Leader for Discovery and Engineering at IONTAS since February 2022. Prior to this role, Caroline was the Head of Discovery at Avacta from October 2020 to January 2022, overseeing Affimer selections and early stage screening processes. Caroline's extensive experience in biopharmaceuticals includes a significant tenure at GSK as an Investigator in Biopharm Discovery from April 2007 to October 2020, where responsibilities included antibody engineering and leading discovery campaigns. Earlier career positions include being a Research Scientist at Domantis and Cambridge Antibody Technology, focusing on antibody engineering and protein expression. Caroline Dimech earned a PhD in Molecular Pharmacology from the University of Reading and completed undergraduate studies at the University of York.
Sign up to view 1 direct report
Get started